However, the protective effect of GSK-3β inhibition was mostly demonstrated in LPS-induced sepsis models and only a few studies explored the possible effect of GSK-3β inhibition against live bacteria, which is more similar to clinical conditions [26]. This evidence concerns the gene GSK3B and Sepsis.